HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors

被引：48
|
作者：
Wainberg, MA [1 ]
机构：
[1] McGill Univ, AIDS Ctr, Jewish Gen Hosp, Montreal, PQ, Canada
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2003年 / 34卷
关键词：
nevirapine; NNRTI; resistance; HIV-1;
D O I：
10.1097/00126334-200309011-00002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Nevirapine and other members of the non-nucleoside reverse transcriptase inhibitor (NNRTI) family of anti-HIV-1 drugs are essential components of antiretroviral treatment regimens. Unfortunately, drug resistance has become an important issue with respect to all therapeutic targets in HIV-1. This paper summarizes current knowledge about the mutations in the reverse transcriptase gene of HIV-1 that are responsible for drug resistance and the mechanisms whereby drug resistance develops.
引用
收藏
页码：S2 / S7
页数：6
相关论文
共 50 条
  • [1] Resistance to non-nucleoside inhibitors of HIV-I reverse transcriptase
    Bacheler, LT
    [J]. DRUG RESISTANCE UPDATES, 1999, 2 (01) : 56 - 67
  • [2] Mechanisms of resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Boyer, PL
    Tantillo, C
    Ding, J
    Ferris, AL
    Clark, P
    Arnold, E
    Hughes, SH
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 6 - 6
  • [3] HIV-1 reverse transcriptase resistance to non-nucleoside inhibitors.
    Spence, RA
    Johnson, KA
    [J]. BIOPHYSICAL JOURNAL, 1996, 70 (02) : MP356 - MP356
  • [4] Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase
    Sweeney, Zachary K.
    Acharya, Sahaja
    Briggs, Andrew
    Dunn, James P.
    Elworthy, Todd R.
    Fretland, Jennifer
    Giannetti, Anthony M.
    Heilek, Gabrielle
    Li, Yu
    Kaiser, Ann C.
    Martin, Michael
    Saito, Y. David
    Smith, Mark
    Suh, Judy M.
    Swallow, Steven
    Wu, Jeffrey
    Hang, Julie Q.
    Zhou, Amy S.
    Klumpp, Klaus
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4348 - 4351
  • [5] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [6] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [7] Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase
    Ren, Jingshan
    Stammers, David K.
    [J]. VIRUS RESEARCH, 2008, 134 (1-2) : 157 - 170
  • [8] The role of nucleic acid in the resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Arnold, E
    Das, K
    Ding, JP
    Hsiou, Y
    Tantillo, C
    Roy, BM
    Yadav, P
    Zhang, WY
    Lentz, K
    Clark, AD
    Boyer, PL
    Hughes, SH
    Mitsuya, H
    Mellors, J
    Kleim, JP
    Rosner, M
    Moereels, HR
    Koymans, L
    Andries, K
    Pauwels, R
    Janssen, PAJ
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 7 - 7
  • [9] In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz
    Kollmann, C
    Tremblay, C
    Giguel, F
    Chou, TC
    Hirsch, MS
    [J]. ANTIVIRAL THERAPY, 2001, 6 (02) : 143 - 144
  • [10] Non-nucleoside reverse transcriptase (NNRTI) inhibitors
    不详
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (14) : 747 - 748
12345